Top

BMC Pulmonary Medicine

Published in:

Open Access 01-12-2018 | Study protocol

Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH)

Authors: Norman R. Morris, Menaka Louis, Wendy Strugnell, Julie Harris, Aaron Lin, John Feenstra, Helen Seale

Published in: BMC Pulmonary Medicine | Issue 1/2018

Abstract

Background

Exercise training is an integral component of evidence-based management programs for many chronic cardiac and respiratory conditions. Despite this, there are limited high-quality studies available on the significance of exercise training in pulmonary hypertension (PH). The aim of this study is to evaluate the short and long-term effectiveness of exercise training in PH patients in terms of exercise capacity, quality of life, cardiac function and disease progression.

Methods

This randomized control trial will aim to recruit 50 medically stable PH patients categorised as New York Heart Association functional classification II-III. Participants will be randomly allocated to either the supervised exercise training group or usual care group for the 8-week study period. Exercise training will be conducted in an outpatient setting. Measurements at baseline and following the 8-week study period include exercise capacity (6 min walk distance and cardiopulmonary exercise test), cardiac function (exercise cardiac magnetic resonance imaging [CMRI] and echocardiography), health-related quality of life (Cambridge Pulmonary Hypertension Outcome Review), adverse responses to exercise training and time to clinical worsening. In addition, participants will be followed up for a minimum of 2 year period from commencement of the study so as to monitor long-term clinical outcomes i.e. time to clinical worsening.

Discussion

This study will determine whether an 8-week outpatient based supervised exercise training program is safe and beneficial for medically stable PH patients in the short and long term. This will be the first study to examine the impact of exercise training on right heart function using exercise CMRI. Results from the study will contribute new knowledge in relation to the impact of exercise training on cardiac function, long-term prognosis and inform clinical practice guidelines for this patient population. Moreover, the study will add to our understanding regarding the efficacy of exercise training in individuals with PH in an outpatient setting.

Trial registration

Australia and New Zealand Clinical Trials Registry: ACTRN12616001467426. Registered 21st October, 2016.

Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42–50.CrossRefPubMed

Swiston JR, Johnson SR, Granton JT. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med. 2010;104(11):1588–607.CrossRefPubMed

Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188(3):365–9.CrossRefPubMedPubMedCentral

Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.CrossRefPubMed

Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, MD MG, VV ML, Preston IR, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D60–72.CrossRefPubMed

Morris NR, Seale H, Harris J, Hall K, Hopkins PM, Kermeeen FD. Serious adverse events during a 6-min walk test in pulmonary hypertension. Eur Respir J. 2015;45:1179–82.CrossRefPubMed

Grunig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012;40(1):84–92.CrossRefPubMed

Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114(14):1482–9.CrossRefPubMed

Babu AS, Padmakumar R, Maiya AG, Mohapatra AK, Kamath RL. Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart Lung Circ. 2016;25(4):333–41.CrossRefPubMed

10.

Buys R, Avila A, Cornelissen VA. Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials. BMC Pulm Med. 2015;15:40.CrossRefPubMedPubMedCentral

11.

Pandey A, Garg S, Khunger M, Garg S, Kumbhani DJ, Chin KM, Berry JD. Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circ Heart Fail. 2015;8(6):1032–43.PubMed

12.

Yuan P, Yuan XT, Sun XY, Pudasaini B, Liu JM, Hu QH. Exercise training for pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol. 2015;178:142–6.CrossRefPubMed

13.

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75.CrossRefPubMed

14.

Morris N, Royston D, Jayasinghe R, Sabapathy S. Heart failure patients have impaired thermoregulatory response during exercise (884.2). FASEB J. 2014;28(1 Supplement):884–2.

15.

Morris NR, Kermeeen FD, Holland AE. Exercise-based rehabiltation for pulmonary hypertension. Cochrane Database for Syst Rev. 2017;1:CD011285.

16.

Chan L, Chin LM, Kennedy M, Woolstenhulme JG, Nathan SD, Weinstein AA, Connors G, Weir NA, Drinkard B, Lamberti J, et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143(2):333–43.CrossRefPubMed

17.

Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J. 2016;37(1):35–44.CrossRefPubMed

18.

Ley S, Fink C, Risse F, Ehlken N, Fischer C, Ley-Zaporozhan J, Kauczor HU, Klose H, Gruenig E. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol. 2013;23(2):324–31.CrossRefPubMed

19.

Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2010;30(5):319–23.CrossRefPubMed

20.

Whaley MH, Brubaker PH, Otto RM, Armstrong L. American College of Sports Medicine’s guide to clinical exercise testing and prescription, vol. 9. Philadelphia: Lippincott Williams & Wilkins; 2013.

21.

Holland A, Hill K, Alison J, Luxton N, Mackey M, Hill C, Jenkins S. Estimating peak work rate during incremental cycle ergometry from the 6-min walk distance: differences between reference equations. Respiration. 2011;81(2):124–8.CrossRefPubMed

22.

Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, MC MC, Carlin BW, Sciurba FC, Pitta F, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.CrossRefPubMed

23.

Morris NR, Adams L, Johnson BD, Weisman I. Exercise limitations and cardiopulmonary exercise testing in COPD. In: Stockley RA, Rennard S, Rabe K, Celli B, editors. Chronic Obstuctive Pulmonary Disease. Edn. Mass: Blackwell Publishing; 2007. p. 40–62.CrossRef

24.

Morris NR, Seale H, Harris J, Hall K, Lin AC, Kermeen F. Gas exchange responses during six minute walk test in patients with pulmonary arterial hypertension. Respirology. 2017;22(1):165–71.CrossRefPubMed

25.

Morris NR, Adams L, Johnson BD, Weisman IM, Stockley RA, Rennard SI, Rabe K, Celli B. Exercise limitations and cardiopulmonary exercise testing in COPD. Chron Obstruct Pulmon Dis. 2008;40–63.

26.

Ganderton L, Jenkins S, SP MK, Gain K, Fowler R, Twiss J, Gabbay E. Validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for the Australian and New Zealand population. Respirology. 2011;16(8):1235–40.CrossRefPubMed

27.

SP MK, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge pulmonary hypertension outcome review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15(1):103–15.CrossRef

28.

Lin AC, Strugnell WE, Seale H, Schmitt B, Schmidt M, O'Rourke R, Slaughter RE, Kermeen F, Hamilton-Craig C, Morris NR. Exercise cardiac MRI-derived right ventriculo-arterial coupling ratio detects early right ventricular maladaptation in PAH. Eur Respir J. 2016;48(6):1797–800.CrossRefPubMed

29.

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. quiz 786-688.CrossRefPubMed

30.

Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, MD MG. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(5):1521–9.CrossRefPubMed

31.

Grunig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, Opitz CF, Klose H, Wilkens H, Rosenkranz S, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011;81(5):394–401.CrossRefPubMed

32.

Pulido T, Adzerikho I, Channick RN, Delcroix M, Galie N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369(9):809–18.CrossRefPubMed

33.

Chakraborty H, Gu H. A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values. Research Triangle Park: RTI Press publication No. MR-0009-0903. RTI International; 2009.CrossRef

34.

Addetia K, Bhave NM, Tabit CE, Gomberg-Maitland M, Freed BH, Dill KE, Lang RM, Mor-Avi V, Patel AR. Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging. 2014;7(1):115–24.CrossRefPubMed

35.

Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010;122(2):164–72.CrossRefPubMed

36.

Taylor RS, Sagar VA, Davies EJ, Briscoe S, Coats AJS, Dalal H, Lough F, Rees K, Singh SJ, Mordi IR. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014;(4). Art. No.: CD003331.

37.

Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4(4). Art. No.: CD003793. https://doi.org/10.1002/14651858.CD003793.pub2.

38.

Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, MD MG, VV ML, Preston IR. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25):D60–72.CrossRefPubMed

Title: Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH)
Authors: Norman R. Morris
Menaka Louis
Wendy Strugnell
Julie Harris
Aaron Lin
John Feenstra
Helen Seale
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI: https://doi.org/10.1186/s12890-018-0586-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH)

Abstract

Background

Methods

Discussion

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning

Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

Pulmonary actinomycosis mimicking a lung metastasis from esophageal cancer; a case report

Balloon pulmonary angioplasty – efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis – a case report

Chyloptysis with chylopericardium, a rare case and mini-review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page